期刊文献+

肾透明细胞癌中环氧化酶-2与血管内皮细胞生长因子的表达及其相关意义 被引量:2

The expression and significance of COX-2 and VEGF in clear renal cell carcinoma
原文传递
导出
摘要 目的探讨肾透明细胞癌中环氧化酶-2(COX-2)、血管内皮细胞生长因子(VEGF)的表达及其相关意义。方法采用免疫组化法检测60例原发性肾透明细胞癌、10例正常肾组织中COX-2和VEGF的表达。结果COX-2在肾透明细胞癌中的阳性表达率(76.7%)高于正常肾组织(20%)(X^2=10.28,P〈0.01)。VEGF在肾透明细胞癌中的阳性表达率(73.3%)高于正常肾组织(20%)(X^2=8.58,P〈0.01)。肾透明细胞癌中COX-2表达与VEGF表达呈正相关(r=0.469,P〈0.01)。结论COX-2、VEGF的表达参与了肾透明细胞癌的发生、发展,COX-2、VEGF的表达可作为肾透明细胞癌发生、发展动态过程中的客观观察指标,二者的协同作用强化了肿瘤的恶性演进。 Objective To study the correlation between vascular endothelial growth factor(VEGF) and cyclooxygenase-2(COX-2) in clear renal cell carcinoma (CRCC). Methods In 60 cases of CRCC and 10 cases of normal renal tissue, immunohistochemistry was used to examine the expression of COX-2 and VEGF. Results The positive expression rate of COX-2 in CRCC (76. 7% ) was significantly higher than that in normal renal tissue (20%) ( X^2 = 10. 28, P 〈 0. O1 ). The positive expression rate of VEGF in CRCC(73.3% ) was significantly higher than that in normal renal tissue (20%) (X^2=8.58, P 〈0. 01). The expressions of COX-2 and VEGF in CRCC were correlated with each other ( r = 0. 469, P 〈 0.01 ). Conclusions The expressions of COX-2 and VEGF were involved in the pathophysiolical processes of clear renal cell carcinoma. The expression levels of COX-2 and VEGF might be used to evaluate the development of clear renal cell carcinoma.
出处 《中国医师杂志》 CAS 2013年第3期293-295,共3页 Journal of Chinese Physician
基金 辽宁省科技厅科学技术计划项目(2010225032)
关键词 肾肿瘤 病理学 腺癌 透明细胞 病理学 环氧化酶2 代谢 内皮生长因子 代谢 Kidney neoplasms/pathology Adenocareinoma, clear celL/pathology Cyclooxygenase 2/metabolism Endothelial growth factors/metabolism
  • 相关文献

参考文献13

二级参考文献58

共引文献12

同被引文献29

  • 1张灿斌,李简,郑建,王强.胃管成形术在食管重建中的可行性研究[J].河南科技大学学报(医学版),2005,23(3):175-179. 被引量:128
  • 2郑劲平,陈荣昌,钟南山.肺功能学[M].广州:广东科学技术出版社,2007:322-347.
  • 3Ferguson MK,Durkin AE.Preoperative prediction of the risk ofpulmonary complications after esophagectomy for caneer[J].J Thorac Cardiovasc Surg,2008,123(4):661-669.
  • 4Avendano CE,Flume PA,Silvestri GA,et al.Thdraonary compli-cations after esophageetomy[J].Ann Thorac Surg,2009,73(3):922-926.
  • 5Panebianeo V,Franeioni F,Anzidei M,et al.Magnetic resonance-fluoroscopy as long-term follow-up examination in patients withnalTow gastric tube reconstruction after radical esophagectomy[J].Eur J Cardiothorae Surg,2006,30(4):663.
  • 6Ikeda Y,Niimi M,Kan S,et al.Clinical significance of tissueblood flow during esophagectomy by laser Doppler tlowmetry[J].J Thorac Cardiovasc Surg,2009,122(6):1101-1106.
  • 7Heitmiller RF.Impact of gastric tube diameter on upper mediasti-nal anatomy after transhiatal esophagectomy[J].Diseases of theEsophagus,2010,13(1):288-292.
  • 8Linkslnda AM,Andrini LB,Garcia MN,et al.Evaluation of angio-genesis with the expression of VEGF and CD34 in human non-small cell lung cancer[J]. J Exp Clin Cancer Res,2007,26(3):375-378.
  • 9Takala H,Saamio J,Wiik H,et al.HIF-Ia and VEGF are associ-ated with disease progression in esophageal carcinoma[J].SurgRes,2011,167(1):4148.
  • 10Shimada H,Takeda A,Naberya Y,et al.Clincal significance ofserum vascular endothelial growth factor in esophageal squamouscell carcinoma[J].Cancer,2007,92(3):663-669.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部